Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Alok K. Tewari et al.|Cancer Cell|2021Cited by 624
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Cancer Immunology Research|2022Cited by 88
Data from Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Unknown|2023Cited by 1
Data from Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Unknown|2023Cited by 0
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Unknown|2023Cited by 0